• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation

tetano

Editor, Senior Moderator
Cell


. 2021 Jul 7;S0092-8674(21)00833-3.
doi: 10.1016/j.cell.2021.07.007. Online ahead of print.
A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation


Lin Kang[SUP] 1 [/SUP], Guijuan He[SUP] 2 [/SUP], Amanda K Sharp[SUP] 3 [/SUP], Xiaofeng Wang[SUP] 2 [/SUP], Anne M Brown[SUP] 4 [/SUP], Pawel Michalak[SUP] 5 [/SUP], James Weger-Lucarelli[SUP] 6 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) pandemic underscores the need to better understand animal-to-human transmission of coronaviruses and adaptive evolution within new hosts. We scanned more than 182,000 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes for selective sweep signatures and found a distinct footprint of positive selection located around a non-synonymous change (A1114G; T372A) within the spike protein receptor-binding domain (RBD), predicted to remove glycosylation and increase binding to human ACE2 (hACE2), the cellular receptor. This change is present in all human SARS-CoV-2 sequences but not in closely related viruses from bats and pangolins. As predicted, T372A RBD bound hACE2 with higher affinity in experimental binding assays. We engineered the reversion mutant (A372T) and found that A372 (wild-type [WT]-SARS-CoV-2) enhanced replication in human lung cells relative to its putative ancestral variant (T372), an effect that was 20 times greater than the well-known D614G mutation. Our findings suggest that this mutation likely contributed to SARS-CoV-2 emergence from animal reservoirs or enabled sustained human-to-human transmission.

Keywords: COVID-19; SARS-CoV-2; emergence; molecular virology; selective sweep; spillover; viral adaptation.
 
Back
Top Bottom